- Curaleaf ( OTCPK:CURLF ) said its cannabis based medicines were registered as extract in Poland, with local partner CanPoland.
- Curaleaf added that the licensed product, 100%-European sourced from plant to manufacture, is part of its unit Curaleaf International's proprietary product range which has now launched in five European markets, including the U.K. and Germany.
- In addition to the Polish license, Curaleaf International previously announced registrations of products in Malta and registering a THC cannabis extract active pharmaceutical ingredient (API) in Italy.
For further details see:
Curaleaf cannabis products get registration in Poland